Nepal Considers Banning E-Cigarette Sales Due to Rising Youth Usage

Regulations by 2FIRSTS.ai
Apr.09.2024
Nepal Considers Banning E-Cigarette Sales Due to Rising Youth Usage
Nepal considers banning e-cigarette sales due to rising youth usage and concerns over health risks, reports MyRepublica.

According to a recent report by MyRepublica, the Information Officer at the Nepal Health Education, Information and Communication Center believes that Nepal may ban the sale of e-cigarettes in the future.

 

Nepal is currently facing an issue of increasing e-cigarette usage among teenagers. According to statistics, Nepal's e-cigarette imports are projected to reach 3.2 million units by 2023, with an estimated market value of 21 billion Nepalese Rupees (approximately $15.8 million USD). Despite research indicating that e-cigarette vapor is at least 95% less harmful than smoking, Nepal considers the potential harm of e-cigarettes to be on par with traditional tobacco burning, based on health concerns.

 

According to a recent survey by the Nepal Development Research Institute, 34.1% of the population in Nepal smoke, showing an increase from 31.8% in 2020.

 

Researcher Kamal Chaulagain from the Nepal Development Studies Institute believes that the increasing popularity of tobacco consumption is due to the growing prevalence of hookahs and e-cigarettes, with some users viewing them as alternatives to traditional smoking. He also calls for an increase in tobacco taxes. Jaya Kumar Gurung, the director of the Nepal Development Studies Institute, accuses the weak enforcement of anti-smoking legislation, emphasizing the lack of public awareness regarding the harmful effects of tobacco products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK Peer Seeks to Weaken “Generational Smoking Ban” – Report Reveals Discussions with BAT Executive Relative
UK Peer Seeks to Weaken “Generational Smoking Ban” – Report Reveals Discussions with BAT Executive Relative
Lord Strathcarron, a member of the UK House of Lords, has admitted to discussing the government’s Tobacco and Vapes Bill with a relative who holds a senior role at British American Tobacco (BAT). He is advocating amendments to scrap the bill’s core “generational smoking ban” provision, raising questions of potential conflict of interest.
Oct.27
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Russian State Duma passes first reading of bill to ban tobacco and e-cigarette sales at public transport stops
Russian State Duma passes first reading of bill to ban tobacco and e-cigarette sales at public transport stops
Russia's State Duma passes first reading of bill banning tobacco and e-cigarette sales at public transport stops. (20 words)
Oct.22 by 2FIRSTS.ai
JUUL Labs Accuses NJOY and Altria of Patent Infringement; U.S. ITC Launches Section 337 Investigation
JUUL Labs Accuses NJOY and Altria of Patent Infringement; U.S. ITC Launches Section 337 Investigation
The U.S. International Trade Commission (USITC) has instituted an investigation titled Certain Vaporizer Devices, Cartridges Used Therewith, and Components Thereof (II) based on a complaint by JUUL Labs, Inc. JUUL alleges that NJOY, its parent and affiliates at Altria Group, infringed U.S. Patent No. 12,156,533 through the importation and sale of certain ENDS devices, cartridges, and components. JUUL seeks a limited exclusion order and cease-and-desist orders. Respondents must answer within 20 d
Sep.11 by 2FIRSTS.ai
Imperial Brands Urges Retailers to Engage in Government Consultation on Tobacco and Vapes Bill
Imperial Brands Urges Retailers to Engage in Government Consultation on Tobacco and Vapes Bill
Imperial Brands is calling on UK retailers to take part in the Government’s consultation on the Tobacco and Vapes Bill, which will shape a new licensing framework for nicotine product sales across England, Wales and Northern Ireland. The Department of Health and Social Care’s call for evidence closes on 3 December 2025. Imperial Brands stresses this is a key chance for retailers to influence policy, support fair competition, and help curb illicit sales.
Nov.04
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
British American Tobacco has paused the U.S. pilot launch of its unlicensed Vuse One vape amid intensified FDA enforcement.
Oct.28 by 2FIRSTS.ai